Open AccessManagement Strategy of Hyperthermic State in Critically Ill Patient
Author(s) -
Alfred Ibrahimi,
Saimir Kuçi,
Ervin Bejko,
Stavri Llazo,
Jonela Burimi,
Esmerilda Bulku,
Edvin Prifti,
Andi Kaçani
Publication year - 2018
Publication title -
albanian journal of trauma and emergency surgery
Language(s) - English
Resource type - Journals
eISSN - 2616-4922
pISSN - 2521-8778
DOI - 10.32391/ajtes.v2i2.24
Subject(s) - medicine , intensive care medicine , renal replacement therapy , sepsis , acute kidney injury , septic shock , critically ill , pharmacotherapy
Pyrexia is a protective physiologic response of the body against external and internal aggression. Temperature control is safe in and effective in septic shock but remain controversial in sepsis. Treating pyrexia to reduce oxygen consumption appears to have beneficial in cardiac arrest, low cardiac output and acute brain injury. Multiple therapeutic options are available for managing pyrexia, with precise targeted temperaturemanagement. Notably, the use of pharmacotherapy versus surface cooling has not been shown to be advantageous. When these two-therapy failed to control the extra-corporal method of cooling should be started. Renal replacement therapies are not typically indicated for temperature control but, in patients requiring renal support, they contribute to heat loss and participate in pyrexia control. Renal replacement therapies may represent a confounding factor in comparative trials on temperature control.